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Abstract
Fisherian randomization inference is often dismissed as testing an uninteresting and implausible
hypothesis: the sharp null of no effects whatsoever. We show that this view is overly narrow.
Many randomization tests are also valid under a more general “bounded” null hypothesis under
which all effects are weakly negative (or positive), thus accommodating heterogenous effects.
By inverting such tests we can form one-sided confidence intervals for the maximum (or mini-
mum) effect. These properties hold for all effect-increasing test statistics, which include both
common statistics such as the mean difference and uncommon ones such as Stephenson rank
statistics. The latter’s sensitivity to extreme effects permits detection of positive effects even
when the average effect is negative. We argue that bounded nulls are often of substantive or
theoretical interest, and illustrate with two applications: testing monotonicity in an IV analysis
and inferring effect sizes in a small randomized experiment.
1 Motivation
Randomization inference (RI), also known as permutation inference, is a general statistical frame-
work for learning about treatment effects. RI originated with R. A. Fisher [1935], who demon-
strated that if treatment is randomly assigned to units, the hypothesis that no unit was affected by
treatment—the so-called “sharp null of no effects”—can be tested exactly, with no further assump-
tions, by comparing an observed test statistic with its distribution across alternative realizations of
treatment assignment.1 Moreover, by testing a sequence of hypotheses, randomization tests can also
∗Authors can be reached at devin.caughey@gmail.com, allandafoe@gmail.com, and lmiratrix@g.harvard.edu. For
helpful input we thank Peter Aronow, Jake Bowers, Joanna Dafoe, Danny Hidalgo, Greg Huber, Kosuke Imai, Luke
Keele, Kelly Rader, Brandon Stewart, and seminar participants at PolMeth 2016. We also thank the late Natasha
Chichilnisky-Heal for posing the question that stimulated some of our thinking on this paper.
1 More precisely, a randomization test of the sharp null of no effects is a valid test, meaning that its whose true
false-rejection rate is no greater than (as opposed to exactly equal to) its significance level α.
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be used to create exact nonparametric confidence intervals (CIs) for treatment effects [Lehmann,
1963]. RI thus provides a unified framework of statistical inference that requires neither parametric
assumptions about the data-generating distribution nor asymptotic approximations that may be
unreliable in small samples (Rosenbaum [2002], but for applications in political science, see Ho
and Imai [2006], Keele et al. [2012], Bowers et al. [2013], Glynn and Ichino [2014], Caughey et al.
[2017]).2
Despite its virtues, RI has also been subject to trenchant critiques. One stems from the claim
that RI can only be used to test sharp null hypotheses—that is, hypotheses that stipulate the
treatment effect of each unit. Since sharp hypotheses often have little prior plausibility, rejecting
them arguably conveys little information of scientific or substantive value. A second line of criticism,
related to the first, is that extending RI from hypothesis testing to interval estimation requires
assumptions that are arguably as strong as those of its parametric and large-sample competitors.
In particular, deriving interpretable CIs typically requires the assumption that all treatment effects
are constant (that is, do not vary across units), which is often highly implausible, especially in
the social sciences. For these reasons, social-science methodologists and applied researchers have
typically viewed RI as a highly limited tool, useful primarily for assessing whether treatment had
any effect at all.
These critiques have substantial merit, but we argue that they are based on an overly restrictive
and pessimistic view of RI. We show that many randomization tests can in fact be interpreted as
conservative tests of a “weak” null hypothesis—that is, one under which unit-level effects are
heterogeneous and need not be precisely stipulated. Specifically, we prove that for a broad class of
randomization tests, one-sided rejection of the sharp null that all treatment effects τi equal some
constant τ0 also implies rejection of any null hypothesis under which the τi are bounded on one
side by τ0. This means that RI can be used test the non-superiority null that all effects are less
than or equal to τ0 (τi ≤ τ0 ∀i) or, alternatively, the non-inferiority null τi ≥ τ0 ∀i. We refer to
2 RI’s finite-sample validity provides an important contrast with nonparametric methods that rely on asymptotic
approximations, such as average treatment effect (ATE) estimation. For example, Welch’s unequal-variances t test,
which is an asymptotically conservative nonparametric test of the ATE [Samii and Aronow, 2012], is often considered
highly robust, even in moderately sized samples of n = 30. But even the t test can be quite inaccurate if the sample
sizes differ between treatment and control and the response distributions are skewed [e.g., Hesterberg, 2015, 372].
Appendix A.1 illustrates this with the example of a skewed beta distribution and sample sizes of n1 = 1000 and
n2 = 30. Under these conditions, the t test with α = 0.01 falsely rejects the null of mean equality over 10% of the
time. By contrast, Fisher’s difference-of-means permutation test maintains exact coverage under these conditions.
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these as bounded null hypotheses.
We show that any randomization test of a given sharp null will be valid under the corresponding
bounded null, as long as it employs an effect-increasing test statistic. Loosely speaking, an effect-
increasing test statistic is one that increases in value as the treated responses increase and the
control responses decrease.3 Although some test statitics, such as Student’s t statistic, are not
effect-increasing, many commonly used statistics are, including the difference of means and the
Wilcoxon rank sum.
Compared to the sharp null of no effects, bounded null hypotheses are much more plausible
a priori. They are also normatively important. In order for a treatment or intervention to be
Pareto improving, for example, it must make at least one person better off while hurting no one.
Thus, rejecting the bounded null hypothesis that all effects are greater than or equal to zero implies
rejection of the hypothesis that a treatment is Pareto improving. At a more technical level, bounded
null hypotheses are also invoked as assumptions by a variety statistical methods. Instrumental
variables estimation, for example, is typically conducted under a monotonicity assumption that
the instrument has non-negative or non-positive effects on the treatment. There are thus many
situations where testing a bounded null hypothesis is of theoretical or practical interest.
In addition to hypothesis testing, our results also provide a basis for interval estimation. Re-
jecting τi = τ
0 ∀i with a one-sided randomization test implies rejection of the bounded hypothesis
τi ≤ τ0 ∀i. Thus, by inverting a sequence of tests for different values of τ0, it is possible to form
a one-sided confidence interval for the maximum treatment effect (analogous logic applies for the
minimum effect). These intervals give a sense of the size of the effects for most impacted units.
They can also be thought of as confidence intervals stating where at least some of the individual
causal effects lie, and the more homogeneous the effects are thought to be, the more effects these
intervals would contain. In particular, when using test statistics sensitive to the central tendency,
inferences on the upper bound will generally coincide closely with inferences for the ATE. As we
demonstrate in our example applications, however, the inferences for the mean and the maximum
can diverge substantially if one uses a test statistic sensitive to extreme treatment effects. Indeed,
3 We borrow the term effect-increasing test statistics from Rosenbaum [2002, 37–8], who discusses them in the
context of power against particular alternatives under the sharp null. Our definitions of effect-increasing differ slightly,
in that Rosenbaum defines it in terms of observed outcomes and we do so in terms of potential outcomes.
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even if the ATE is significantly negative, it is nevertheless possible to conclude that treatment had
at least one positive effect of a given magnitude.
In sum, we offer a novel reinterpretation of randomization inference. We show that RI can do
much more than merely assess whether treatment had any effect at all. Not only are randomization
tests valid under a much less restrictive null hypothesis than is commonly understood, but, unlike
ATE estimators, they can be used to construct interval estimates for the maximum or minimum
treatment effect, a quantity that is often of normative or theoretical interest. All this is possible
without asymptotic approximations or any additional assumptions beyond random assignment and
SUTVA [Rubin, 1980].
The remainder of the paper is organized as follow. After first reviewing existing perspectives
on RI, we illustrate the intuition behind randomization tests’ validity under the bounded null.
We then prove this result formally for the class of effect-increasing test statistics, and show that
this result implies that RI can be used to derive exact confidence intervals for the maximum or
minimum treatment effect. We follow with a discussion of effect-increasing statistics, noting that
more precise confidence intervals can be obtained by using statistics sensitive to extreme effects.
After discussing the practical and theoretical relevance of bounded null hypotheses, we illustrate
its value with two example applications. We then offer brief conclusions.
2 Current Perspectives on Randomization Inference
As noted above, critiques of RI generally focus on two main limitations. The first is that random-
ization tests are valid only under a specific sharp null hypothesis, such as that no unit has any
treatment effect or that all units have the same effect. By contrast, large-sample nonparametric
procedures such as the t test are valid under a so-called “weak” null hypothesis that specifies the
value of some function of the treatment effects, typically the ATE. The sharp null of no effects
implies the weak null of mean equality, but the converse is not true. Indeed, without further
assumptions, permutation tests are not valid tests of a weak null, even asymptotically [Romano,
1990]. For example, if treatment groups have different sizes and variances, rejecting the sharp
null of no effects with a difference-of-means permutation test does not imply that the weak null
of no average effect can also be validly rejected. For these reasons, many scholars follow Neyman
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[1935, 173] in regarding sharp nulls as “uninteresting and academic.” Gelman [2011], for example,
argues that “the so-called Fisher exact test almost never makes sense, as it’s a test of an uninter-
esting hypothesis of exactly zero effects (or, worse, effects that are nonzero but are identical across
all units).” The current consensus among political methodologists is aptly summarized by Keele
[2015, 330], who states that because it does not easily “accommodate heterogeneous responses to
treatment,” the sharp null “would seem to be a very restrictive null hypothesis.”
The crux of this critique, however, concerns not hypothesis testing per se, but rather inference
regarding causal quantities of interest. From this perspective, the real value of Neyman-style causal
inference is not that it permits a given weak null to be tested, but that it provides a basis for interval
estimation of some summary of the unit-level effects, namely their average.4 Confidence intervals
for the ATE indicate the range of plausible values of this parameter that are consistent with the
data. Although CIs can also be constructed within an RI framework, doing so typically requires
the assumption that effects are constant across units. This constant-effects assumption is rightly
viewed as quite strong, especially in social science, “where treatment effect heterogeneity is a rule
rather than an exception.”5 Without some version of this assumption, however, RI as currently
understood provides no basis for drawing exact inferences about the magnitude of treatment effects.
Defenders of randomization inference have responded to these critiques in various ways. Some,
while largely accepting the critiques of the sharp null, argue that RI is nevertheless useful for
assessing whether treatment had any effect at all, as a preliminary step to determine whether
further analysis is warranted [e.g., Imbens and Rubin, 2015]. An alternative proposal, advanced by
Chung and Romano [2013], is to employ “studentized” test statistics that render permutation tests
asymptotically valid under a weak null. Some scholars defend the constant-effects assumption more
forthrightly, regarding it as a convenient approximation that is preferrable to the shortcomings of
parametric methods, such as their sensitity to assumptions about tail behavior [Rosenbaum, 2010]
or inability to account for complex treatment assignments [Ho and Imai, 2006].
It is also possible to model heterogeneity explicitly. Rosenbaum [2002] demonstrates, for exam-
ple, that permutation tests can be used to assess multiplicative, Tobit, quantile, and attributable
4 By interval estimation we mean the calculation of a numerical range to summarize the probable value of an
unknown quantity. By contrast, point estimation summarizes the probable value with a single “best guess.”
5 This quotation is from Kosuke Imai’s lecture notes on permutation tests (2013, 7).
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effects, each of which permits certain precise kinds of heterogeneous additive effects [see also Ho
and Imai, 2006, Bowers et al., 2013]. Indeed, in principle there is no barrier to using RI to assess
any arbitrary null hypothesis, so long as the hypothesis is sharp in the sense that it fully specifies
the unit-level treatment effects (see, e.g., Li and Ding [2016]). In general, however, testing arbi-
trary sharp null hypotheses does not provide informative inferences because the parameter space
is typically too unwieldy (with n units, the space of possible effects is n-dimensional—assuming no
spillover!).
While the defenses described above are reasonable, all presume that randomization tests are
valid only as tests of a sharp null hypothesis. As such, they do not directly address the concerns of
critics who regard sharp nulls as inherently “restrictive,” “uninteresting,” and “academic.” They
also generally focus on testing rather than interval estimation. We show, by contrast, that many
randomization tests are also valid under a bounded null hypothesis, thus substantially expanding
their applicability and permitting assessment of the size as well as significance of treatment effects.
3 Intuition for Validity under the Bounded Null
At the broadest level, Fisher and Neyman shared the same goal: making inferences about the
effects of treatment on a given sample of units, based solely on the assumption that treatment was
randomly assigned. In Neyman’s (1923) terms, both were interested in the differences in potential
outcomes under treatment and control, τi = Yi(1) − Yi(0), for n units indexed by i. Under the
assumption that the potential outcomes Yi(1) and Yi(0) depend only on i’s own observed treatment
status,6 these quantities of interest are fully defined by the potential-outcome schedule S, which
specifies all the potential outcomes in the sample.7 Drawing inferences about the unobserved
elements of the potential-outcome schedule is the core task of causal inference.
As illustration, consider a sample of 16 units, 8 of which have been randomly assigned to
treatment (Wi = 1) and 8 to control (Wi = 0). Table 1 presents what we know about the sample.
For each unit, only one potential outcome is observed; the other potential outcome is missing,
and so is each unit’s treatment effect. Suppose that we are interested in assessing the alternative
6 This is known as the stable unit treatment value assumption, or SUTVA [Rubin, 1980].
7 This is what Rubin [2005, 323–4] calls the “science” table. We use “potential-outcome schedule” to echo
Freedman’s (2009) term “response schedule.”
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hypothesis that units were positively affected by the treatment. Based on the observed outcomes,
we calculate a treated–control difference of means of tobs = Y¯1 − Y¯0 = +1.13. How unlikely is a
difference of means this large, relative to what would be expected by chance?
i Wi Yi Yi(0) Yi(1) τi
1 0 −0.90 −0.90 ? ?
2 0 0.18 0.18 ? ?
3 0 1.59 1.59 ? ?
4 0 −1.13 −1.13 ? ?
5 0 −0.08 −0.08 ? ?
6 0 0.13 0.13 ? ?
7 0 0.71 0.71 ? ?
8 0 −0.24 −0.24 ? ?
9 1 2.98 ? 2.98 ?
10 1 0.86 ? 0.86 ?
11 1 1.42 ? 1.42 ?
12 1 1.98 ? 1.98 ?
13 1 0.61 ? 0.61 ?
14 1 −0.04 ? −0.04 ?
15 1 2.78 ? 2.78 ?
16 1 −1.31 ? −1.31 ?
Table 1. The potential-outcome schedule S for our 16-unit illustration.
Answering this question requires comparing tobs to its reference distribution under some null
hypothesis H0. In the Fisherian paradigm, H0 consists of an n-vector τ
0 of treatment effects,
based on which we can create a null potential-outcome schedule S˜τ0 with the missing potential
outcomes filled in. Using the imputed S˜τ0 , we can “re-run” our experiment on the same units
and calculate the test statistics that would have been observed under alternative permutations of
treatment assignment. The collection of these values across permutations constitutes the statistic’s
reference distribution under the null hypothesis, conditional on the observed data.8 The proportion
of permutations with a value of the test statistic at least as large as tobs is the p-value under H0.
This procedure is most straightforward for the sharp null of no effect. Under this hypothesis,
τi = 0 ∀i, so the missing potential outcomes imputed under this hypothesis simply equal the
observed outcomes (see Table 2, columns 4–5). The same procedure, however, may be used for any
8 We refer to alternative treatment assignments as “permutations,” but strictly speaking treatment assignment
should only be permuted if the size of the treatment group is fixed by design. If, instead, treatment is assigned by
another mechanism, such as binomial randomization, then the reference distribution can be generated accordingly,
or, alternatively, one could condition on the total of units treated. See, e.g., Hennessy et al. [2016] for discussion.
Regardless, our arguments here readily extend to alternative randomization schemes.
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arbitrary vector τ 0 of hypothesized treatment effects. If Wi = 1, we simply impute the missing Yi(0)
as Y˜i(0) = Yi−τ0i . Likewise, if Wi = 0 we impute Y˜i(1) = Yi+τ0i . Columns 7–9 of Table 2 illustrate
this procedure for a constant-effect null of τi = −1 ∀i, and columns 10–12 do so for a bounded null
under which most effects are 0 but two are negative. For any such sharp null, we can generate the
reference distribution by repeatedly permuting the treatment variable W , determining potential
outcomes that would have been observed under that treatment assignment, and calculating the
value of the test statistic in each permutation.9
Observed Data H0: No Effects H0: Constant Effect H0: Non-Superiority
i Wi Yi Y˜i(0) Y˜i(1) τ
0
i Y˜i(0) Y˜i(1) τ
0
i Y˜i(0) Y˜i(1) τ
0
i
1 0 −0.90 −0.90 −0.90 0 −0.90 −1.90 −1 −0.90 −0.90 0
2 0 0.18 0.18 0.18 0 0.18 −0.82 −1 0.18 −1.82 −2
3 0 1.59 1.59 1.59 0 1.59 0.59 −1 1.59 1.59 0
4 0 −1.13 −1.13 −1.13 0 −1.13 −2.13 −1 −1.13 −1.13 0
5 0 −0.08 −0.08 −0.08 0 −0.08 −1.08 −1 −0.08 −0.08 0
6 0 0.13 0.13 0.13 0 0.13 −0.87 −1 0.13 0.13 0
7 0 0.71 0.71 0.71 0 0.71 −0.29 −1 0.71 0.71 0
8 0 −0.24 −0.24 −0.24 0 −0.24 −1.24 −1 −0.24 −0.24 0
9 1 2.98 2.98 2.98 0 3.98 2.98 −1 2.98 2.98 0
10 1 0.86 0.86 0.86 0 1.86 0.86 −1 0.86 0.86 0
11 1 1.42 1.42 1.42 0 2.42 1.42 −1 1.42 1.42 0
12 1 1.98 1.98 1.98 0 2.98 1.98 −1 2.98 1.98 −1
13 1 0.61 0.61 0.61 0 1.61 0.61 −1 0.61 0.61 0
14 1 −0.04 −0.04 −0.04 0 0.96 −0.04 −1 −0.04 −0.04 0
15 1 2.78 2.78 2.78 0 3.78 2.78 −1 2.78 2.78 0
16 1 −1.31 −1.31 −1.31 0 −0.31 −1.31 −1 −1.31 −1.31 0
tobs = +1.13 p = 0.040 p = 0.002 p = 0.027
Table 2. Potential-outcome schedules imputed under the sharp null hypotheses of no effects (columns 4–6),
a constant effect of −1 (columns 7–9), and non-superiority (columns 10–12). The bottom row lists the observed
difference of means (tobs) and its one-sided permutation p-values under the three null hypotheses.
The bottom row of Table 2 first reports tobs, the observed difference of means, and then lists
the p-values of this statistic under each sharp null hypothesis. Notice that the p-values under the
9 See, for example, Ding et al. [2016, 660]. It is worth noting that this procedure differs slightly from that
described by Rosenbaum [e.g., 2002, 44], who instead proposes testing whether the imputed potential outcomes
under control, Y˜i(0) = Yi −Wiτ0i , satisfy the sharp null of no effects. A disadvantage of the Rosenbaum procedure is
its arbitrary choice of Y˜i(0) rather than Y˜i(1) as a baseline. This choice can affect the results of the test if, for example,
the difference of means is the test statistic and the null stipulates heterogeneous additive effects. For intuition on
this point, observe that the vector Y˜(1) imputed under the non-superiority null (Table 2, column 11), because it
incorporates the −2 treatment effect for unit 2, deviates more strongly from the sharp null than does Y˜(0), which
incorporates only the smaller −1 effect for unit 12. The exact p-values under the no-effects null are 0.025 for Y˜(1)
and 0.035 for Y˜(0). In expectation, either test is valid, but for any realized treatment assignment their results can
differ.
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−3 −2 −1 0 1 2
Figure 1. Reference distributions under different null hypotheses. The dark black line is the reference distribution
of t = Y¯1 − Y¯0 under the sharp null hypothesis of no effects. The red dotted line denotes the observed tobs. The
p-value is the area under the curve to the right of this, and as it is small we would reject the null. The dashed green
line is the reference distribution under the null hypothesis of a constant treatment effect of τ0 = −1. The grey lines
are a sample of 10 possible reference distributions for ten different non-superiority nulls of no positive effects. They
are all stochastically lower than the sharp zero null, and thus have lower p-values.
constant-effect null and the bounded null are both smaller than the p-value under the null of no
effects whatsoever. This is no coincidence. Rather, as we later prove, the p-value under any sharp
null that satisfies τi ≤ 0 ∀i is guaranteed to be no larger than the p-value under the sharp null of no
effects (τi = 0 ∀i).10 This result follows from the fact that the reference distribution generated under
the null of no effects weakly stochastically dominates the distribution under any non-superiority
null. This fact is illustrated visually in Figure 1, which plots the reference distribution for the
no-effects null (solid black line), the constant-effects null of −1, and ten randomly generated nulls
with heterogeneous treatment effects between −1 and 0. Observe that the density lines of the
heterogeneous-effect nulls are all to the left of the solid no-effects density line and to the right of
the dashed constant-effect line. Consequently, the cumulative density greater than tobs (vertical
dotted line)—that is, the p-value—is largest for the no-effect null, smallest for the constant-effect
null, and somewhere in the middle for each of the heterogeneous nulls.
This result has several implications. First, it means that if the sharp null hypothesis of no effect
τi = 0 ∀i can be rejected at level α, so can any null hypothesis such that τi ≤ 0 ∀i.11 In other words,
tests of the no-effect null are conservative tests of the more general bounded null (see Figure 2 for
a visual representation of the relationship between Fisher’s no-effect null and the bounded null).
Moreover, this result extends to any constant-effect null, in that rejection of H0 : τi = τ
0 ∀i implies
10 This presumes that the test statistic is larger in the alternative than under the sharp null. If it is smaller in the
alternative, then the statement holds for any null that satisfies τi ≥ 0 ∀i.
11 Again, assuming without loss of generality that the test statistic is large under the alternative.
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Figure 2. The null hypothesis of non-superiority. The horizontal and vertical axis indicate, respectively, Y˜i(1) and
Y˜i(0): the treated and control potential outcomes imputed under the null hypothesis. The dotted 45
◦ line represents
Fisher’s sharp null of no effects, under which Y˜i(1) = Y˜i(0). The red squares indicate the observed treated outcomes
Yi(1), and the horizontal red lines indicate their possible values of Y˜i(0) under the bounded null. The blue circles
and vertical blue lines indicate the Yi(0) and possible Y˜i(1) for units actually assigned to control.
rejection of H0 : τi ≤ τ0 ∀i. This observation is particularly important for confidence intervals
(CIs), which in RI are defined as the collection of sharp null hypotheses not rejected at a given
significance level. Typically, randomization CIs are calculated under a constant-effect assumption,
but the above result suggests an alternative interpretation that does not require this assumption.
Under this re-interpretation, a one-sided randomization CI for a constant effect is also a valid CI
for the lower bound on the maximal unit-level effect, τmax. Thus, an α-level CI of [L,∞) will miss
the true τmax with probability α, and we can conclude with 100× (1−α)% confidence that at least
some units had a treatment effect as large as L.
For intuition, consider the example of a newly developed drug, whose side effects on pain we
wish to compare to those of an existing drug. In particular, we wish to assess whether the new
drug increases any subject’s pain level Yi relative to the existing drug. Given random assignment
to the existing drug (Wi = 0) and the new (Wi = 1), we can do so using an appropriate one-sided
permutation test of the null hypothesis H0 : Yi(1)− Yi(0) ≡ τi = τ0 ∀i for a sequence of τ0 values.
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If L, the smallest value of τ0 that cannot be rejected at α = 0.1, is greater than 0, then we can
conclude with 90% confidence that the new drug caused at least one subject at least L more pain
than the existing drug would have. In other words, we can conclude not only that the sharp null
of no effects is implausible, but that at least one subject was adversely affected by the new drug.
4 Formal Exposition of Validity under the Bounded Null
Having illustrated the intuition behind our argument, we now turn to formal exposition. As noted
above, permutation tests are conventionally conducted under a sharp null hypothesis that precisely
specifies the n-vector of unit-level treatment effects τ . Let Hτ0 denote the sharp null hypothesis
τ = τ 0, where τ 0 is a vector of hypothesized treatment effects, not necessarily equal to 0 or any
other constant. Testing such a sharp null hypothesis entails first choosing a test statistic T (W,Y ),
which is a function of the treatment assignment vector W and the observed outcomes Y .12 Since Y
is itself a function of W and the potential outcomes Y (0) and Y (1), with Yi = Yi(Wi), we can also
write the test statistic as T (W,Y (0), Y (1)) = T (W, S). S being fixed, the randomness in T (W, S)
comes only from the randomness in W .13 Examples of test statistics include the treated-control
difference of means,
T (W, S) =
∑
WiYi(1)/
∑
Wi −
∑
(1−Wi)Yi(0)/
∑
(1−Wi), (1)
but there are many other options, several of which we discuss later in the paper.
The observed value of the test statistic is tobs = T (wobs,yobs), where wobs and yobs are, re-
spectively, the observed treatment and outcome vectors. To evaluate whether a test statistic value
as large as tobs would be unusual under the null hypothesis, we compare it to its permutation
distribution under the null. Being sharp, Hτ0 allows us to impute the potential-outcomes schedule
12We are simplifying the exposition by considering univariate outcomes and by ignoring covariates. More generally,
however, a test statistic may be a function of multiple outcome variables as well as of covariates.
13Strictly speaking, the T (W, S) notation allows for statistics not directly observable (e.g., ones that use both
potential outcomes of the units). We use this notation for later clarity in the formal argument, with the implicit
restriction of T (W, S) that could also be represented as T (W,Y ), a function of the observed data.
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under the null, S˜τ0 = S˜(wobs,yobs,Hτ0), through the relations
Y˜i(0) =

wi = 0 y
obs
i
wi = 1 y
obs
i − τ0i
and
Y˜i(1) =

wi = 0 y
obs
i + τ
0
i
wi = 1 y
obs
i .
Using S˜τ0 , we can then compute the test statistic value that would have been observed under any
alternative realization of W . Let w∗ denote a random draw from the space of potential treatment
assignments, and let t∗ = T (w∗, S˜τ0) be the value of the test statistic given w∗ and S˜τ0 .14 The
p-value of tobs under Hτ0 is thus the probability across permutations of observing a test statistic
value at least as large as tobs:
pτ0 ≡ P
{
T (w∗, S˜τ0) ≥ tobs
}
. (2)
This exact p-value can be estimated to arbitrary precision by sampling J random permutations of
treatment w∗j and calculating
pˆτ0 =
1
J
J∑
j=1
1
{
T (w∗j , S˜τ0) ≥ tobs
}
≈ pτ0 . (3)
We next show that, for a class of effect-increasing test statistics, a test of the sharp null is
actually a valid test of the much more general bounded null hypothesis, under which the treatment
effects are bounded on one side by the sharp null but otherwise may be arbitrarily heterogeneous.
When the test statistic is an increasing function of the treatment effects, such as the difference of
means, this bounded null is one of non-superiority—that is, one bounded above by the sharp null:
Hτ∨ : τi ≤ τ∨i ≡ τ0i ∀i ∈ 1 . . . n. (Non-Superiority)
14 The assignment vector W is random according to an assignment mechanism which returns a specific w with
given probability P{W = w}. For instance, in the completely randomized design, P{W = w} = ( N
NT
)−1
for any w
such that
∑
wi = NT for some pre-specified NT . In most typical experiments, all treatment assignments that have
non-zero probability are equiprobable.
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Analogously, when the test statistic is decreasing in treatment effects, the weak null is a lower
bound of non-inferiority :
Hτ∧ : τi ≥ τ∧i ≡ τ0i ∀i ∈ 1 . . . n. (Non-Inferiority)
For ease of exposition we here focus on the non-superiority null Hτ∨ , which we simply refer to as
the bounded null, but all our results can be extended to Hτ∧ by multiplying Y by −1.
Unlike the sharp null Hτ0 , which corresponds to a single null potential-outcomes schedule S˜τ0 ,
the bounded null Hτ∨ corresponds to an infinitely large set of such schedules that are consistent with
the observed data and the treatment-effect bound (e.g., every set of points on the lines in Figure 2).
Thus, if we reject this null, we are rejecting a set of null schedules (and associated treatment-effect
vectors) rather than a single point null. Because each weak null permits infinitely many possible
potential-outcome schedules, each of which implies a different null distribution for the test statistic,
no single p-value will be exact (i.e., have a false-positive rate of exactly α) for all possible schedules.
We can show, however, that for a class of test statistics the p-value associated with any of these
null distributions will be bounded above by the p-value under Hτ0 , making the sharp null p-value
valid but possibly conservative for the bounded null. (A hypothesis test is conservative if, for any
nominal significance level α, the true probability of incorrectly rejecting the null hypothesis is no
greater than α.)
The above property holds for permutation tests that employ an effect-increasing test statistic.
To define this class of statistics, we must first introduce the notion of ordering potential-outcome
schedules:
Definition: Ordering of Potential-Outcome Schedules. Two potential-outcome schedules
S and S′ are ordered as S  S′ if Yi(1) ≤ Y ′i (1) and Yi(0) ≥ Y ′i (0) ∀i ∈ 1 . . . n. That is, S  S′ if and
only if no unit’s potential outcome under treatment is smaller in S′ than in S and no unit’s potential
outcome under control is larger in S′ than in S. An immediate consequence of such ordering is that
the individual treatment effects are also ordered: τi ≤ τ ′i ∀i.
Our class of statistics is then defined as those that satisfy the following:
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Definition: Effect-Increasing (EI). A test statistic T is effect-increasing if, for two potential-
outcome schedules S and S′, S  S′ implies T (w, S) ≤ T (w,S′) for all allowed realizations w of the
treatment variable W . In other words, a test statistic T is effect-increasing if it is weakly increasing
in the potential outcomes under treatment and weakly decreasing in the potential outcomes under
control [cf. Rosenbaum, 2002, 37–8]. Since S  S′ implies τi ≤ τ ′i ∀i, an EI statistic is also increasing
in the individual treatment effects (hence the label “effect-increasing”).
For effect-increasing statistics we have the following proposition:
Proposition 1. If τ0 = τ
∨, a permutation test of Hτ0 is a conservative (and thus valid) test of
Hτ∨ in that for all Sh ∈ Hτ∨
P{Reject Hτ∨ |Sh} = P
{
T (w∗, S˜τ0) ≥ T (w, Sh)
}
≤ α,
with the probabilities taken across both w and w∗, each random draws from the assignment mech-
anism. (For a formal proof of this propoosition, see Appendix A.2.)
This result means that if we consider a test of a given sharp null as a test of the associated
bounded null, we still have a valid test. In particular, rejecting Hτ∨ when the nominal p-value for
a permutation test of Hτ0 is less than α is a valid testing procedure for Hτ∨ .
5 Confidence Intervals for Maximum/Minimum Effects
In most settings, researchers are not content merely to test a single null hypothesis. Rather, they
wish to summarize the information the data convey regarding quantities of interest. One way to
do this is to estimate confidence intervals that indicate the range of plausible parameter values.
Because of the duality between hypothesis testing and interval estimation, a general method of CI
construction is to define the 1 − α% CI as the set of parameter values that cannot be rejected at
some significance level α. In the case of a one-sided t test, for example, the lower bound of the 90%
CI for the mean µ is the smallest value of µ0 such that the weak null hypothesis µ ≤ µ0 cannot
be rejected at α = 0.1. Analogously, in the case of an effect-increasing randomization test, the
lower bound of the CI for the maximum unit-level effect τ∨i is the smallest value of τ
0 such that
the non-superiority hypothesis τi ≤ τ0 ∀i cannot be rejected.
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For sharp null inference, confidence intervals are generally obtained by inverting a sequence of
sharp-null level-α tests of hypotheses Hτ0 . Typical practice would be to consider a sequence of
constant shift hypotheses Hτ0 : τi = τ
0 ∀i. For each candidate value τ0h = τ0 we calculate
p(τ0h) = P
{
T (w∗, S˜τ0h) ≥ t
obs
}
,
and if p(τ0h) ≤ α, we conclude that τ0h is implausible. This gives a confidence set of plausible τ0
values of
CI ≡ {τ0h : p(τ0h) ≥ α} .
The confidence sets are random depending on the randomization. They are valid in the sense that if
the treatment effect is in fact constant (S ∈ Hτ for some τ), then the confidence set CI will contain
τ with probability at least 1 − α. Unfortunately, if the treatment effect is not constant, there is
no immediate reason for CI to contain any particular summary of the treatment effects (e.g., the
ATE). This is one of the primary complaints against permutation inference.
By viewing these as tests of a bounded null, however, the associated confidence interval does in
fact have a general interpretation that does not depend on the implausible assumption of constant
effects. In particular, the conventional randomization CI for a constant effect can be interpreted
as a confidence set on the maximum treatment effect in the sample (or minimum, in the case of
a non-inferiority hypothesis). In other words, given a one-sided CI [L,∞) we can say that we
are at least 1 − α confident that some units have a treatment effect of at least L. (For a proof
of this proposition, see Section A.3 in the Appendix.) This statement does not depend on any
specific structure on the individual effects; they may be arbitrarily heterogeneous. That being said,
the more homogenous the effects, the more individual effects we would expect to be in the CI.
Of course, in the limiting case of no effect heterogeneity (i.e., a constant effect), [L,∞) will, as
discussed above, contain all the individual effects with probability 1− α.
It should be emphasized that the permutation CI for the maximum effect will have correct
coverage regardless of the test statistic used, as long as that statistic is effect-increasing. The
CI itself will, however, vary depending on the test statistic’s power against different alternative
hypotheses. In particular, unless the treatment effects are close to constant, using a statistic
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sensitive to the central tendency may result in relatively uninformative confidence bounds for the
maximum. Thus, if heterogenous effects are expected, it may be preferable to use a statistic that
is sensitive to the largest effects, such as the Stephenson rank sum (discussed below).
6 Effect-Increasing Test Statistics
All effect-increasing test statistics are valid under the bounded null, but what are they? We next
show that the difference of means, the Wilcoxon rank sum, and other common test statistics are all
effect-increasing. We also note that others, in particular the studentized difference of means, are
not. We then briefly touch on the issue of statistical power against different alternative hypotheses.
As discussed above, an effect-increasing statistic grows as the treatment potential outcomes get
larger or the control potential outcomes get smaller. The difference in means, T (Y,W ) = Y¯1 − Y¯0,
is an intuitive example of such a statistic: if we increase any Yi(1) then the difference in means
will either go up (if Wi = 1) or remain unchanged (if Wi = 0). Similarly, if we lower any Yi(0) the
control side mean will either shrink, which will raise t, or stay the same. This general argument
applies for several broad classes of statistics, as we present below in two lemmas. Proofs are in
Appendix A.4.
First, statistics that look like differences in means, or sums of rescaled treatment outcomes, are
all effect-increasing:
Lemma 1. Let Q(·) be a non-decreasing function of outcomes and a(W ), b(W ) ≥ 0 be two scaling
numbers that can depend on treatment assignment. Then the class of statistics defined as
T (Y,W ) = a(W )
n∑
i=1
WiQ(Yi)− b(W )
n∑
i=1
(1−Wi)Q(Yi)
are effect-increasing. The difference-in-means is a special case with a(W ) = 1/nT , b(W ) = 1/nC ,
and Q(Yi) = Yi.
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Furthermore, many common rank statistics are also effect-increasing:
15As a mild technical condition, define a(W ) and b(W ) as constant when there are no treated or no control units
in the case of assignment mechanisms that have variable numbers of units treated.
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Lemma 2. For continuous outcomes any statistic of the form
T (W,Y ) = a(W )
∑
i
WiQ(Ri)− b(W )
∑
i
(1−Wi)Q(Ri),
where Ri is the rank of Yi, a(W ) and b(W ) are nonnegative functions of the assignment vector,
and Q(Ri) is some non-decreasing function of the ranks, is effect-increasing.
For many statistics this result extends to outcomes with ties. In particular, see Appendix A.4 for
derivations for the Wilcoxon rank sum statistic and Stephenson rank sum statistics (see below).
The EI property does not hold, however, if the difference of means is “studentized” by a con-
sistent estimate of its standard error:
t =
Y¯T − Y¯C√
s2T /NT + s
2
C/NC
.
The t statistic is not EI because a large increase in one unit’s treated outcome can have such a large
effect on the standard deviation sT that it outweighs the effect on the mean Y¯T , thus decreasing the
statistic overall. More obviously, statistics not sensitive to one-sided location shifts—such as the
absolute difference of means, the difference of variances, and the two-sided Kolmogorov-Smirnov
statistic—are also not effect-increasing.
Any effect-increasing statistic will give a valid test of the general bounded null. They are not all
the same, however. In particular, a given statistic can be more or less sensitive to different alterna-
tives, which can influence power. One class of statistics particularly well-suited to this circumstance
are Stephenson rank statistics [Stephenson, 1981, Stephenson and Ghosh, 1985]. Stephenson rank
statistics are two-sample statistics with a score function of
Q(Ri) =

(
Ri−1
s−1
)
Ri ≥ s
0 otherwise
for some fixed integer s ≥ 2. Stephenson rank statistics are equivalent to summing the number
of subsets of size s in which the largest response is in the treated group. The Stephenson rank
statistic with s = 2 is almost identical to the Wilcoxon rank sum. However, as s increases beyond
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2, the Stephenson ranks place more and more weight on the largest responses.
Stephenson rank statistics are particularly interesting in the context of this paper due to their
power to detect uncommon-but-dramatic responses to treatment [Rosenbaum, 2007]. Intuitively,
this is because as the subset size s increases, it becomes increasingly likely that the largest response
in a given subset will be one with an unusually large treatment effect.16 Thus, compared to
the difference of means and the Wilcoxon rank sum, whose power is greatest against a constant
location shift, the Stephenson ranks have greater power against alternatives under which effects
are heterogeneous and a few are highly positive (relative to the null). This sensitivity to extreme
treatment effects leads to tighter confidence intervals for the maximum effect when the maximum
differs greatly from the mean or median. It is even possible for a Stephenson rank test to reject
the non-superiority null for positive values when the ATE estimate is negative, if some treatment
effects are sufficiently positive. Thus, when treatment effects are heterogeneous, the behavior of
the Stephenson test can differ markedly from the rank sum or difference of means, while, like them,
still providing a valid test of the bounded null hypothesis.
7 Practical and Theoretical Relevance
So far, we have demonstrated that effect-increasing randomization tests can be interpreted as tests
of a bounded null hypothesis, that inverting a sequence of such tests produces valid confidence
intervals for the maximum effect, and that many familiar test statistics are effect-increasing. But
do these formal results have any practical relevance, or are they as “uninteresting and academic”
as the sharp null? We believe that both testing bounded null hypotheses and interval estimation
for maximum or minimum effects are indeed relevant to many social-scientific questions.
There are many settings where bounded null hypotheses are either invoked as technical assump-
tions or given special normative status; in either case, testing and possibly rejecting the bounded
null is both scientifically interesting and practically meaningful. Many statistical techniques, for in-
stance, rely on a monotonicity assumption that one causal variable has non-negative or non-positive
effects on another. Instrumental-variable (IV) estimation, Manski bounds, mediation analysis, the
16 Examining the asymptotic relative efficiency of a closely related class of test statistics, Conover and Salsburg
[1988, 196] find that when a only small fraction of treated respond, the optimal subset size s is between 5 and 6.
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signing of paths on directed acyclic graphs, and the signing of selection bias are all examples of
such methods. Obviously, the monotonicity assumption is equivalent to the hypothesis that the
unit-level effects are bounded at 0 on one side. In many social contexts, the monotonicity as-
sumption is considered “reasonable” [Morgan and Winship, 2007, 206], “plausible” [Imbens and
Rubin, 2015, 452], or at least “defensible” [Gelman and Hill, 2006, 217], suggesting that reject-
ing it and other bounded null hypotheses can be substantively interesting. Even applied studies
that explicitly invoke monotonicity, however, usually do not test it empirically, perhaps because
doing so fits poorly with conventional methods’ focus on average effects. As we show in Section
8.1, our re-interpretation of randomization inference provides a straightforward basis for evaluating
monotonicity.
In addition to being invoked as substantive assumptions to justify using certain statistical
methods, bounded null hypotheses frequently have special normative or theoretical significance.
From a normative perspective, there are many circumstances where “nonmaleficence,” or avoidance
of harm, is an important moral standard: even if the overall or expected effect of an action would
be beneficial, one nevertheless has an obligation to avoid harming any individual [e.g., Beauchamp
and Childress, 2012, chapter 5]. According to this standard, a policy or other intervention whose
average or median effect is positive may nevertheless be ethically objectionable if it has a single
negative effect. This emphasis on avoiding harm even if the net benefit is positive appears in many
contexts, ranging from U.S. tort law to experimental moral philosophy [e.g., in variants of the
“trolley problem”; Thomson, 1985]. A related ethical standard, prominent in economics, is “Pareto
improvement”—a change in the allocation of resources that increases average welfare while hurting
no one. If, for example, campaign contribution limits benefit all citizens, even campaign donors
themselves [Coate, 2004], then from a consequentialist perspective there should be no objection
to such limits. By contrast, a policy that benefits most but harms some, such as a free-trade
agreement without an adequate compensation scheme for losers, may fail to pass ethical muster.17
Whether couched as nonmaleficence or Pareto improvement, the ethical standard is again a bounded
17 When compensation schemes are workable then finding a Pareto-optimal policy simplifies to maximizing the
ATE and implementing such a compensation scheme. However, compensations schemes are often not workable. The
outcome, such as quality-adjusted life years, may not be fungible. Compensation schemes may not be incentive
compatible, or may be costly to implement. Most fundamentally, compensation schemes require estimating with
sufficient precision every person’s counterfactual gain or loss—that is, their individual treatment effect—which is
generally impossible without strong assumptions.
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Figure 3. Two one-sided confidence intervals for maximum and minimum effects (blue lines). The confidence
intervals [L,∞) and (−∞, U ] do not overlap in this illustration, which is possible if they are based on a test statistic
sensitive to the tails of the distribution of treatment effects (e.g., the Stephenson rank sum).
hypothesis, which we may wish to test empirically.
Of course, scholars generally seek to infer not only the sign of treatment effects, but also
their magnitude. Our results are relevant for these purposes as well. In some circumstances, for
example, it may be of interest whether a treatment had any effect large enough to be “policy
relevant” or otherwise substantively important. If such a relevance threshold can be stipulated
a priori, then an effect-increasing randomization test of the null hypothesis that all effects are
bounded by this threshold provides an answer to this question. If the hypothesis is rejected, then
we can conclude that there were in fact some policy-relevant effects. Randomization CIs provide a
more general answer to this question, enabling readers with possibly differing thresholds to come to
their own conclusions. With test statistics sensitive to the extremes, it is even possible to test and
form confidence intervals for policy-relevant effects in opposite directions. If effects are sufficiently
heterogeneous, the two confidence intervals may not even overlap, indicating the presence of both
positive and negative effects beyond thresholds of substantive importance (see Figure 3). This
inference may take on particular significance in small samples. If we can conclude, for example,
that at least one unit in a 20-unit sample had a policy-relevant effect, then, informally speaking,
this provides evidence that 5% of the larger population would experience such an effect. In short,
both tests of bounded null hypotheses and confidence intervals for maximum or minimum effects
can help answer questions of practical and theoretical relevance to applied researchers, a fact we
illustrate with the applications that follow.
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8 Applications
We illustrate the practical implications of our results with re-analyses of two published studies. In
the first, we show how randomization tests’ validity under the bounded null provide a basis for
assessing the assumption that an instrumental variable has monotonic effects on the treatment.
In the second application, we show how RI can be used to make inferences about effect sizes in a
16-unit randomized experiment.
8.1 Testing Monotonicity of an Instrumental-Variable Analysis
The assumption that the instrument has monotonic effects on the treatment, though conventionally
invoked for identification of IV estimates [Angrist et al., 1996], is rarely evaluated in empirical
applications. Recently, however, the issue of non-monotonicity has received attention in the active
literature on school-entry age, which numerous studies instrument for using laws regulating entry
age (Aliprantis [2012], Barua and Lang [2016], for an overview, see Fiorini and Stevens [2014]).
Typically, these laws select an arbitrary date of birth before which children are allowed to enter
school in given calendar year. If the cutoff date is January 1, for example, most children born in
December will be about 11 months younger when they enter school than children born in January.
Due to imperfect compliance with the instrument, however, some fraction of December children
may “redshirt” and start the following school year, at which time they will be one month older
than than January children who started on time. Unless the December children who redshirt would
also have redshirted had they been born in January, monotonicity is violated. That is, the effect
of December birth on school-entry age is typically negative, but for a few children it is positive (an
analogous logic holds for January children who start early).
For a simple illustration of how RI can be used to evaluate monotonicity, we re-analyze data
on 104,000 children from Black et al.’s (2011) IV study of school-entry age, which have previously
been analyzed from a sampling-based perspective by Fiorini and Stevens [2014]. The latter authors
note that the cumulative distribution functions (CDFs) of December- and January-born children in
these data cross each other, suggesting a violation of monotonicity.18 Figure 4 indicates this clearly.
18 The crossing could also indicate that the instrument is not exogenous, but here we assume that birth month is
as-if randomly assigned. Based on an asymptotic test of stochastic dominance, Fiorini and Stevens [2014] reject the
null that the true CDFs do not cross.
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Figure 4. Empirical CDF of school-entry age by birth month (Black et al. [2011]).
Most children started school at an older age if they were born in January rather than December.
Indeed, this first-stage relationship is incredibly strong, with an average effect of 0.7 years and
an F statistic of 106,146. This would conventionally be considered persuasive evidence of a valid
instrument. Note, however, that at the tails of the distribution the relationship between month
of birth and entry age reverses: January birthdays predominate among the youngest starters, and
December does so among the oldest.
If we designate January birth as the assigned-to-treatment condition, then the monotonicity
assumption is equivalent to the null hypothesis of non-inferiority: being born in January did not
cause any child to go to school at an earlier age than they would have if born in December. We test
the non-inferiority null using two different effect-increasing test statistics. The first is simply the
January–December difference in the proportion of starting ages above 7.67 years (or, equivalently,
above the 92.5th percentile of the pooled distribution). The second is the Stephenson rank statistic
with subset size 10.19 Under either test, the null hypothesis of non-inferiority can be rejected with
19 In this application, the performance of Stephenson tests with different subset sizes is essentially given by the
redshirting rate among December births, which is 15%. Specifically, the Stephenson rank statistic totals the number
of times a December child will be oldest in a random subset of size m, which is equal to the probability that the
subset includes either (a) at least one redshirted December child or (b) no on-time January children. Non-inferiority
is resoundingly rejected for all subset sizes greater than m = 6.
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an exact p-value less than 10−16. We can therefore confidently conclude that being born in January
decreased school-entry age for at least some students: the IV monotonicity assumption is violated
in this application.20
8.2 Inferring Effect Sizes in a Small-Sample Experiment
For our second application, we move from the relatively easy task of testing hypotheses in a large
sample to the more challenging one of inferring effect sizes in a very small one. Specifically, we re-
analyze data from Wantchekon [2003], who convinced Beninese presidential candidates to randomly
vary the content of their campaigns across villages.21 The original experiment involved three
conditions, but our re-analysis focuses on two: a treatment condition consisting of a purely policy-
based campaign and a control condition consisting of a mix of policy and clientelist messages. In
each of 8 electoral districts, one village was assigned to each condition, for a total of 16 paired units.
Wantchekon’s main expectation was that policy campaigns would be relatively ineffective and thus
would decrease candidate vote share relative to mixed campaigns. However, given that the same
policy proposal may evoke divergent reactions from different groups of voters, it is plausible that
the policy campaign had heterogenous effects, a possibility noted by Wantchekon [2003, 413].22 Of
interest, then, is not only whether policy campaigns were generally less effective but also whether
for at least some villages they were more effective—and if so, by how much.
The entire 16-unit dataset is displayed in Figure 5, which plots village-level vote share in each
of the two treatment conditions (policy and control). As indicated by the hollow circles, average
candidates’ vote share in the policy condition was almost 6 percentage points lower than in the
control condition, which is consistent with Wantchekon’s main hypothesis that policy campaigns
were generally less effective. This difference, however, is not statistically significant. A paired t test
yields a one-sided p-value of 0.23 and two-sided 90% CI that ranges from −19 to +8 percentage
points (see Figure 6, top line). Permutation tests using the difference of means or the Wilcoxon
20 It may still be worthwhile to go forward with the analysis, perhaps conducting a sensitivity analysis for the
resulting bias. But it should be noted that redefining the treatment in terms of a dichotomous age cut-off (e.g., below
7.67 years), which would seem to restore monotonicity, would violate the portion of SUTVA that rules out hidden
versions of treatment (in this case, different entry ages all defined as “below 7.67”).
21 The village-level data are reported in Table 2 of Wantchekon [2003, 412].
22 According to the original paper all the mean differences between treatment conditions (and even individual
villages) are highly statistically significant, but, as Green and Vavreck [2008] note, Wantchekon’s analysis ignores
village-level clustering and thus vastly overstates the precision of the estimates.
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Figure 5. Data from the policy and control conditions of Wantchekon [2003]. Hollow circles indicate group means.
Villages in the same district are connected by gray lines.
rank sum yield very similar two-sided CIs for a constant treatment effect (Figure 6, second line).
Based on these results, it would appear that the sample size of this experiment is too small to
support firm inferences about the magnitude of treatment effects.
We can say more, however, by focusing on extreme effects rather than typical (e.g., average)
ones. If treatment effects are heterogeneous, then using a test statistic sensitive to the most negative
or positive effects can provide greater power. Indeed, as Figure 5 indicates, the policy condition
contains both the two smallest and the two largest observations in the sample. This pattern is
consistent with the possibility that despite the negative difference of means, policy campaigns
were more effective than the control in at least some villages. We can assess this hypothesis
formally using the Stephenson rank test. Testing the non-superiority null against the alternative
of some positive effects, we obtain an exact significance level of p∨ = 22/256 ≈ 0.086, providing
evidence that the policy campaign treatment was indeed more effective in at least some villages.23
There is only slightly weaker evidence that the policy treatment also had at least one negative
effect: a Stephenson rank test of the non-inferiority null gives p∧ = 32/256 = 0.125. By the
intersection-union principle [Berger, 1982], we can simultaneously reject both the non-inferiority
and non-superiority hypotheses at p = max(p∨, p∧) = 0.125. There is thus suggestive evidence
that treatment had at least one negative and at least one positive effect.
By inverting the Stephenson rank tests, we can also make inferences about the magnitude of
these effects. The lower bound of the one-sided 90% CI for the maximum effect of the policy
treatment is +1.0 points, and the lower bound of the 80% interval is +2.0 (Figure 6, bottom line).
23 This is for the Stephenson ranks with subset size m = 6, but p-values for m = 7, 8, 9 and 10 are also around
0.09. Since villages were randomized pairwise within districts, the total number of possible treatment assignments is
28 = 256.
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Figure 6. Confidence intervals for various causal quantities in Wantchekon [2003]. The vertical dashed line labeled
τˆ indicates the observed difference of means between the policy and control conditions. The horizontal lines labeled
“Average” indicate two-sided 80% and 90% CIs for the ATE, derived from a paired t test. The lines labeled “Constant”
are analogous CIs derived from the Wilcoxon rank sum test under the assumption that treatment effects are constant.
The lines labeled “Minumum” and “Maximum” indicate the CIs for the minimum and maximum treatment effects,
derived from Stephenson rank tests.
The upper bound on the maximum effect, deduced from vote share’s theoretical range, is +93.0.24
The analogous CIs for the minimum effect are, respectively, [−86.0, +5.0] and [−86.0, −11.1]
(Figure 6, third line).25 Note that the 80% CIs for the minimum and maximum effects do not
overlap with one another, which is consistent with the evidence that the policy treatment had both
negative and positive effects. Indeed, the gap between them (−11.1 to +2.0) suggests that the
effects varied quite a bit in magnitude. In sum, even in a small sample where mean differences are
uninformative, RI enables us to make inferences about treatment effects well beyond the simple
conclusion that “treatment had some effect.” Moreover, these inference are exact rather than
approximate, rely on no assumptions beyond SUTVA and random assignment, and without further
assumptions could not be made with other methods.
9 Conclusion
The rise of nonparametric causal inference in the tradition of Neyman [1923] and Rubin [1974] has
been one of the most important recent developments in quantitative social science. This perspective,
with its focus on average treatment effects and its acceptance of effect heterogeneity as the rule
rather than the exception, has rightly prompted greater skepticism of statistical methods that
heavily rely on parametric models or assumptions. It is then perhaps no surprise that permutation
24 If the outcome variable were unbounded, the outer bounds of the maximum and minimum CIs would be ∞ and
−∞, respectively. But since the range of the outcome is [−100, 100], we can deduce the maximum possible treatment
effect from the observed data.
25 The large difference between the 90% and 80% bounds for the minimum effect is driven by the large gaps between
observations at the low end of the policy group.
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inference, which has traditionally been motivated in terms of shift hypotheses or other highly
structured models of treatment effects [e.g., Lehmann, 1975, Rosenbaum, 2002], has also been
regarded with some skepticism despite its freedom from many distributional assumptions.
We have shown that the view of permutation tests now dominant—that despite these tests’
virtues, they are useful only for assessing the typically uninteresting and implausible sharp hypoth-
esis that treatment had no effect at all—is too limited. We have proved that permutation tests
using effect-increasing test statistics are valid under a more general bounded null, that this fact
can be exploited to derive confidence intervals for the maximum effect, and that many familiar test
statistics are effect-increasing. We have also highlighted the value of less familiar statistics such as
the Stephenson rank sum, which is sensitive to the extremes of the treatment effect distribution,
and explained the normative and theoretical relevance of bounded null hypotheses. Finally, we
have re-analyzed a well-known experiment to demonstrate that, when coupled with the new inter-
pretation we have advanced, permutation tests can yield substantively interesting inferences about
treatment effects that are not possible based on ATE estimation alone.
In sum, we have developed a novel perspective on permutation tests that we hope tempers the
skepticism that many social scientists hold towards this otherwise-appealing mode of statistical
inference. Permutation tests are by no means a cure-all; nor are they a substitute for ATE estima-
tion when that is the goal of the analysis. But in many cases, particularly when samples are small,
treatment groups unequal, or treatment assignment complex, they are the most reliable form of
statistical inference. Moreover, even when this is not the case, they often make possible inferences
about treatment effects that other methods cannot. For these reasons, permutation tests deserve
a secure place in the quantitative social scientists’ toolbox.
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A Supplementary Appendix
A.1 The t Test with Skewness and Unequal Sample Sizes
The following code gives rejection rates of 17% against the null with a nominal α of 5%, demon-
strating how the t test can fail even in moderate-sized samples if there is a strong skew.
1 ### DGP with one small group and one large , and skew.
2 n1 <- 30
3 n2 <- 1000
4 alpha <- .2
5 beta <- 20
6 ## Plot density
7 plot(seq(0, 1, 0.01) , dbeta(seq (0 ,1 ,0.01), alpha , beta), type="l")
8 ## Simulations
9 sims <- 10000
10 ps <- rep(NA, sims)
11 set.seed (1)
12 for (i in 1:sims){
13 ys <- rbeta((n1 + n2), 0.1, 5) ## beta
14 zs <- sample(c(rep(1, n1), rep(0, n2)), replace=FALSE)
15 ps[i] <- as.numeric(t.test(ys ~ zs , var.equal=FALSE)[3]) ## Welch/Neyman
16 }
17 ps <- ps[!is.na(ps)]
18 length(ps)
19 mean(ps < 0.01)
20 mean(ps < 0.05)
A.2 Proof of Validity under the Bounded Null
Proof: Let Sh ∈ Hτ∨ be any potential-outcomes schedule satisfying the non-superiority null hy-
pothesis τi ≤ τ∨i ≡ τ0i ∀i ∈ 1 . . . n. Suppose Sh holds. We randomize the units and obtain wobs,
yobs, and tobs = T (wobs, Sh). We then impute S˜τ0 = S˜(wobs,yobs,Hτ0) and obtain p˜, our nominal
p-value. Even though Hτ∨ holds, Hτ0 might not, and so it is possible that S˜τ0 6= Sh and thus p˜ 6= p.
However, if the test statistic is effect-increasing, then we can place a bound on p˜. In particular,
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note that
Y˜i(1) =

Yi(1) w
obs
i = 1
Yi(0) + τ
0
i otherwise
for all i ∈ 1 . . . n. Under Hτ∨
τ0i ≥ τi = Yi(1)− Yi(0),
so
Yi(1) ≤ Yi(0) + τ0i
and thus
Yi(1) ≤ Y˜i(1).
In other words, every true potential outcome under treatment is no larger than its imputed equiv-
alent. By analogous logic Yi(0) ≥ Y˜i(0). These inequalities imply Sh  S˜τ0 . Since T (W, S) is
effect-increasing, T (w, Sh) ≤ T (w, S˜τ0) for any realization W = w. In other words, because the
potential-outcome schedules are ordered Sh  S˜τ0 , the values of T simulated from S˜τ0 will be
pointwise weakly larger than T ’s true reference distribution. As a consequence,
p˜ = P
{
T (w∗, S˜τ0) ≥ tobs
}
≥ P
{
T (w∗, Sh) ≥ tobs
}
= p,
i.e., the estimated p-value will be at least as large as the true one. This gives a valid (though
potentially conservative) test:
P{p˜ ≤ α} ≤ P{p ≤ α} ≤ α.

A.3 Proof of Validity of CI for Maximum Effect
In this section, we prove that conventional confidence intervals for a constant treatment effect are
valid nonparametric intervals for the maximum effect. To show this, we first need a small lemma:
Lemma 3. For our one-sided testing case, and regardless of the character of the true S, the one-
sided CI for an effect-increasing statistic will be a half-interval [L,∞), indicating that the constant-
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shift treatment effect is no smaller than L.
Proof: Say our CI is not a half-interval. Then there exists τ1 < τ2 such that τ1 is not in CI and τ2
is. But the proof of our main result shows that if we are testing Hτ02 then the p-value will be lower
for any S′  S˜, including the one corresponding to a constant treatment effect shift of τ1 < τ2. But
this means τ1 would not be in CI, which is a contradiction. Therefore the CI is a half-interval. 
These confidence intervals can easily generalize to bounded nulls. Let CI be the above confidence
set generated by inverting a sequence of constant-effect nulls. Now consider the true potential-
outcomes schedule S. Assuming all potential outcomes are defined, let
τ∗ ≡ arg max
i
τi
be the largest treatment effect in schedule S. Then Hτ∨ : τi ≤ τ∗ ∀i is true, and so testing the
associated Hτ0 : τi = τ
∗ ∀i will reject with probability no greater than α. We therefore will include
τ∗ ∈ CI with probability no less than 1− α, giving a valid CI for the maximum effect.
A.4 Effect-Increasing Statistics
Many statistics are effect-increasing. In this appendix we first prove that differences in rescaled
outcomes are effect-increasing. We then show that a general class of rank-based statistics is EI in
the absence of ties, and then extend this results to the case of ties for, the rank-sum and Stephenson
rank-sum statistics, two primary statistics discussed in the paper.
Proof (Lemma 2): Let Qi = Q(Yi) denote the observed scores, and let Qi(1) = Q(Yi(1)) and
Qi(0) = Q(Yi(0)) indicate the scores of the potential outcomes. Denote as S(W, S) any statistic
with the form a(W )
∑
iWiQ(1)i = a(W )
∑
iWiQi with a(W ) ≥ 0, i.e., the scaled sum of the scores
of the treated observations.26 We first show that for any S(W, S) and any pair of potential-outcome
26 Note that as Q(Yi) depends only on unit i, not on the entire vector Y . This is a crucial difference from the
class of sum statistics defined by Rosenbaum [2002, 35]. As a result of this distinction, the class of statistics S(W, S)
defined here excludes rank statistics because the rank of Yi depends on the values of other observations. We treat
ranks statistics separately below.
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schedules S  S′, S(W, S) ≤ S(W, S′):
Yi(1) ≤ Y ′i (1) ∀i =⇒ Qi(1) ≤ Q′i(1) ∀i b/c Q(Yi) is non-decreasing in Yi
=⇒ Qi(1)−Q′i(1) ≤ 0 ∀i
=⇒
∑
Wi[Qi(1)−Q′i(1)] ≤ 0 b/c every element is ≤ 0
=⇒
∑
[WiQi(1)]−
∑
[WiQ
′
i(1)] ≤ 0
=⇒ a(W )
∑
[WiQi(1)] ≤ a(W )
∑
[WiQ
′
i(1)]
=⇒ S(W, S) ≤ S(W, S′).
The above includes the special case of the sum of the treated responses,
∑
iWiY (1)i, for which
Q(Yi) = Yi and a(W ) = 1. The intuition behind the above is that raising any individual potential
outcome on the treatment side will either (if the unit was treated) increase
∑
iWiY (1)i or (if the
unit was not treated) not affect the test statistic at all.
This extends to differences the scaled sum of scores as in the lemma because the scaled negative
of the sum of the control scores, −b(W )∑[WiQi(0)], is effect increasing, and the sum of two effect
increasing statistics is also effect increasing.
In particular, by letting Q(Yi) = Yi, a(W ) = 1/nT , b(W ) = 1/nC we have our difference in
means as being effect increasing. This also applies to assignment mechanisms with variable numbers
of treated units (once we define a(W ) and b(W ) for those W that have no treated or no control
units).

Proof (Lemma 3): Let the Ri be the ranks of the (adjusted) observed outcomes, Q(·) a mono-
tonic mapping of these ranks to the real numbers, and a(W ), b(W ) nonnegative functions of the
assignment vector.
Consider two schedules S′  S that are identical except that for some specific unit k with
Y ′k(1) ≤ Yk(1). Conceptually consider making S′ by reducing potential outcome Yk(1) for some
specific k, and leaving the other potential outcomes alone.
Now given any assignment vector W , we have Y obsi , i = 1, . . . , n, and Ri, i = 1, . . . , n the
associated ranks. Assume no ties in ranks. By lowering Yk(1) to Y
′
k(1) we potentially could change
34
some ranks. In particular, the rank of unit k could go down and if it does the ranks of some other
units would increase. Let G =
{
j : R′j > Rj and Wj = 1
}
be the set of units in the treatment
group with increased ranks. Let m denote the size of this set. Let j1, . . . , jm be the indices of the
units in G arranged in increasing order by rank, so Rja < Rja+1 . Importantly, for any unit in G,
we have a change of at most 1 rank, so Rja+1 ≥ Rja + 1 ≥ R′ja , giving Q(R′ja) ≤ Q(Rja+1). Because
no unit can increase its rank to above Rk by reducing unit k we have R
′
jm
≤ Rk. Similarly, the
reduced R′k must be less than the rank of any unit in G, giving R
′
k ≤ Rj1 . This gives:
Q(R′k) +Q(R
′
j1) + . . .+Q(R
′
jm−1) +Q(R
′
jm) ≤ Q(Rj1) +Q(Rj2) + . . .+Q(Rjm) +Q(Rk)
due to a pairwise comparison (the first elements of the two sums are ordered, the second, etc., up
to the mth).
This means that T ′ ≤ T because the treatment sum decreases with the change, and as the
control average can only go up (those units impacted in the control group all have ranks that are
larger than they were previously), subtracting this second term also decreases the total. As with
the prior proof, the scaling quantities a(W ) and b(W ) are unchanged, and therefore carry through.
A similar argument shows that T ′ ≤ T if we consider a pair of potential-outcome schedules
where only a single control potential outcome is increased from S to S′.
Finally, take any two potential-outcome schedules S′  S. Generate a chain of potential-
outcome schedules from S′ to S by changing one potential outcome at a time. For example, the
first step in the chain would be to modify S′ to S′′ so Y1(1)′′ = Y1(1) and all other Y ′′i (z) = Y ′i (z).
By transitivity along this sequence we finally have T ′ ≤ T for any W . Therefore, T is potential
outcomes monotonic. 
Examples. If Q(r) = r we have the classic rank sum test. Similarly, if
Q(r) =
(
r − 1
s− 1
)
for r ≥ s and Q(r) = 0 otherwise
for some fixed s (representing how many subsets of size s can be formed where our unit with rank
r is biggest), we have the Stephenson Rank test.
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Ties. Unfortunately, this general proof does not go through if there are ties. This is because by
lowering a potential outcome, an entire group of mid-ranks can shift. Consider the case where the
original ranks of treated units are 2, 2, 2, 8 and we lower the rank-8 so much that it becomes rank
1. The other units then will have ranks 3, 3, 3 giving final ranks of 1, 3, 3, 3. Now, if Q(r) = 0 for
r < 3 and 1 otherwise, the sum of the four goes from 1 to 3. The control units are unaffected. This
violates the monotonicity. Many specific rank based statistics are, however, EI even in the presence
of ties. This can be shown by direct proof. We next do this for the rank-sum and the Stephenson
rank-sum statistics.
The rank-sum test. Let
T (W, S, Hsδ) =
∑
Wirank(Y
obs
i − δW obsi )
This statistic is equivalent to the Mann-Whitney statistic summing all pairs of treatment-control
observations with the treatment beating the control
TMW (W, S) =
∑
i,j
Wi(1−Wj)1
{
Y obsi − δ ≥ Y obsj
}
=
∑
i,j
Wi(1−Wj)1{Yi(1)− δ ≥ Yi(0)}
with 1{a ≤ b} equalling 1/2 if a = b.
Then, for any two potential-outcome schedules with S  S′ we have
1{Yi(1)− δ ≥ Yi(0)} ≤ 1
{
Y ′i (1)− δ ≥ Y ′i (0)
}
since we are moving the left side up and the right side down, which only increases the chance of
having the left side be higher. Plugging this in to our sum of pairwise comparisons easily obtains
our result of TMW (W, S) ≤ TMW (W, S′).
The Stephenson rank test. Represent this statistic as a sum of indicators across all subsets
where the indicator is 1 if a treatment unit is (tied for) the largest. We have, letting G indicate a
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size-s subset of unit indices and G the collection of all such G,
TS(W, S) =
∑
G∈G
HG
where
HG = max
i∈G
Wi s.t. Y˜i ≥ max
j∈G
Y˜j
with Y˜i being an adjusted outcome (i.e., imputed control outcome under the null). The above
simply says that HG is 1 if there is a treated unit that is (tied for) largest value in the set G.
Alternatively, substitute Y obsi for Y˜i.
Then, for any two potential-outcome schedules with S  S′ and a given G we have HG and H ′G
with
HG ≤ H ′G
since for any unit under treatment, Y obsi can only be larger, and for control, smaller. Therefore,
for each subset where a treatment unit was largest for S, we will still see one being largest for S′.
These inequalities sum, giving TS ≤ T ′S for any W , which implies monotonicity.
37
